Cite
HARVARD Citation
Labeur, T. et al. (n.d.). Body composition is associated with poor overall survival and accelerated time to progression in HCC patients treated with sorafenib. HPB. pp. S263-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Labeur, T. et al. (n.d.). Body composition is associated with poor overall survival and accelerated time to progression in HCC patients treated with sorafenib. HPB. pp. S263-. [Online].